Filing Details
- Accession Number:
- 0000905148-25-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-14 16:03:39
- Reporting Period:
- 2025-01-13
- Accepted Time:
- 2025-01-14 16:03:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1287098 | Maxcyte Inc. | MXCT | Services-Commercial Physical & Biological Research (8731) | 522210438 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2012430 | I. David Sandoval | C/O Maxcyte, Inc. 9713 Key West Avenue, Suite 400 Rockville MD 20850 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-01-13 | 4,466 | $4.54 | 41,447 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to cover tax withholding due upon vesting of previously granted restricted stock units. Such "sale to cover" was automatically effected to satisfy tax withholding obligations and does not represent a discretionary trade by the Reporting Person.
Billionaire Hedge Funds
